May 29 |
Zomedica Enhances TRUFORMA(R) Platform With Launch of Advanced Canine Cortisol Assay
|
May 23 |
Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy
|
May 21 |
Zomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
|
May 16 |
Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying
|
May 15 |
Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) Platform
|
May 14 |
Zomedica And 3 Other Stocks Under $3 Insiders Are Buying
|
May 10 |
Zomedica Corp (ZOM) Q1 2024 Earnings: Revenue Climbs Amidst Rising Costs, Aligns with Analyst ...
|
May 10 |
Zomedica Corp. (ZOM) Q1 2024 Earnings Call Transcript
|
May 9 |
Zomedica GAAP EPS of $0.01, revenue of $6.3M
|
May 9 |
Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity
|